135 related articles for article (PubMed ID: 24059241)
21. N-Methyl Mesoporphyrin IX as an Effective Probe for Monitoring Alzheimer's Disease β-Amyloid Aggregation in Living Cells.
Li M; Zhao A; Ren J; Qu X
ACS Chem Neurosci; 2017 Jun; 8(6):1299-1304. PubMed ID: 28281745
[TBL] [Abstract][Full Text] [Related]
22. Solid-state NMR spectroscopy reveals that E. coli inclusion bodies of HET-s(218-289) are amyloids.
Wasmer C; Benkemoun L; Sabaté R; Steinmetz MO; Coulary-Salin B; Wang L; Riek R; Saupe SJ; Meier BH
Angew Chem Int Ed Engl; 2009; 48(26):4858-60. PubMed ID: 19472238
[TBL] [Abstract][Full Text] [Related]
23. Title: insoluble proteins catch heterologous soluble proteins into inclusion bodies by intermolecular interaction of aggregating peptides.
Carratalá JV; Cisneros A; Hellman E; Villaverde A; Ferrer-Miralles N
Microb Cell Fact; 2021 Feb; 20(1):30. PubMed ID: 33531005
[TBL] [Abstract][Full Text] [Related]
24. Coiled-coil inspired functional inclusion bodies.
Gil-Garcia M; Navarro S; Ventura S
Microb Cell Fact; 2020 Jun; 19(1):117. PubMed ID: 32487230
[TBL] [Abstract][Full Text] [Related]
25. Label-free high-throughput screening assay for inhibitors of Alzheimer's amyloid-β peptide aggregation based on MALDI MS.
Zovo K; Helk E; Karafin A; Tõugu V; Palumaa P
Anal Chem; 2010 Oct; 82(20):8558-65. PubMed ID: 20857910
[TBL] [Abstract][Full Text] [Related]
26. Modeling amyloids in bacteria.
Villar-Piqué A; Ventura S
Microb Cell Fact; 2012 Dec; 11():166. PubMed ID: 23272903
[TBL] [Abstract][Full Text] [Related]
27. Novel method for quantitative determination of amyloid fibrils of alpha-synuclein and amyloid beta/A4 protein by using resveratrol.
Ahn JS; Lee JH; Kim JH; Paik SR
Anal Biochem; 2007 Aug; 367(2):259-65. PubMed ID: 17597573
[TBL] [Abstract][Full Text] [Related]
28. Phytomedicines as potential inhibitors of β amyloid aggregation: significance to Alzheimer's disease.
Kumar NS; Nisha N
Chin J Nat Med; 2014 Nov; 12(11):801-18. PubMed ID: 25480511
[TBL] [Abstract][Full Text] [Related]
29. Real-Time Monitoring of Alzheimer's-Related Amyloid Aggregation via Probe Enhancement-Fluorescence Correlation Spectroscopy.
Guan Y; Cao KJ; Cantlon A; Elbel K; Theodorakis EA; Walsh DM; Yang J; Shah JV
ACS Chem Neurosci; 2015 Sep; 6(9):1503-8. PubMed ID: 26212450
[TBL] [Abstract][Full Text] [Related]
30. The prion-like RNA-processing protein HNRPDL forms inherently toxic amyloid-like inclusion bodies in bacteria.
Navarro S; Marinelli P; Diaz-Caballero M; Ventura S
Microb Cell Fact; 2015 Jul; 14():102. PubMed ID: 26160665
[TBL] [Abstract][Full Text] [Related]
31. Light-triggered dissociation of self-assembled β-amyloid aggregates into small, nontoxic fragments by ruthenium (II) complex.
Son G; Lee BI; Chung YJ; Park CB
Acta Biomater; 2018 Feb; 67():147-155. PubMed ID: 29221856
[TBL] [Abstract][Full Text] [Related]
32. Aggregation state-dependent activation of the classical complement pathway by the amyloid beta peptide.
Webster S; Bradt B; Rogers J; Cooper N
J Neurochem; 1997 Jul; 69(1):388-98. PubMed ID: 9202333
[TBL] [Abstract][Full Text] [Related]
33. The Effects of Latrepirdine on Amyloid-β Aggregation and Toxicity.
Porter T; Bharadwaj P; Groth D; Paxman A; Laws SM; Martins RN; Verdile G
J Alzheimers Dis; 2016; 50(3):895-905. PubMed ID: 26836170
[TBL] [Abstract][Full Text] [Related]
34. Surface plasmon resonance imaging of amyloid-β aggregation kinetics in the presence of epigallocatechin gallate and metals.
Cheng XR; Hau BY; Veloso AJ; Martic S; Kraatz HB; Kerman K
Anal Chem; 2013 Feb; 85(4):2049-55. PubMed ID: 23276205
[TBL] [Abstract][Full Text] [Related]
35. [Physico-chemical methods for studing β-amyloid aggregation].
Radko SP; Khmeleva SA; Suprun EV; Kozin SA; Bodoev NV; Makarov AA; Archakov AI; Shumyantseva VV
Biomed Khim; 2015; 61(2):203-18. PubMed ID: 25978387
[TBL] [Abstract][Full Text] [Related]
36. Protein aggregation as bacterial inclusion bodies is reversible.
Carrió MM; Villaverde A
FEBS Lett; 2001 Jan; 489(1):29-33. PubMed ID: 11231008
[TBL] [Abstract][Full Text] [Related]
37. Recombinant-phospholipase A2 production and architecture of inclusion bodies are affected by pH in Escherichia coli.
Calcines-Cruz C; Olvera A; Castro-Acosta RM; Zavala G; Alagón A; Trujillo-Roldán MA; Valdez-Cruz NA
Int J Biol Macromol; 2018 Mar; 108():826-836. PubMed ID: 29101045
[TBL] [Abstract][Full Text] [Related]
38. Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase in neurodegenerative processes and the role of low molecular weight compounds in counteracting its aggregation and nuclear translocation.
Gerszon J; Rodacka A
Ageing Res Rev; 2018 Dec; 48():21-31. PubMed ID: 30254002
[TBL] [Abstract][Full Text] [Related]
39. An Aβ42 variant that inhibits intra- and extracellular amyloid aggregation and enhances cell viability.
Oren O; Banerjee V; Taube R; Papo N
Biochem J; 2018 Oct; 475(19):3087-3103. PubMed ID: 30213841
[TBL] [Abstract][Full Text] [Related]
40. Mammalian prion protein (PrP) forms conformationally different amyloid intracellular aggregates in bacteria.
Macedo B; Sant'Anna R; Navarro S; Cordeiro Y; Ventura S
Microb Cell Fact; 2015 Nov; 14():174. PubMed ID: 26536866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
